(Q37912039)

25 August 2017

1 reference

title

NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions (English)

1 reference

25 August 2017

main subject

cardiovascular disease

1 reference

Hong Zhu

1

1 reference

25 August 2017

Yunbo Li

series ordinal

2

1 reference

25 August 2017

publication date

1 March 2012

1 reference

Cardiovascular Toxicology

25 August 2017

published in

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

39-45

1 reference

https://scigraph.springernature.com/pub.10.1007/s12012-011-9136-9

25 August 2017

exact match

0 references

cites work

Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Enzymatic oxidation of some non-phosphorylated derivatives of dihydronicotinamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Quinone reductases multitasking in the metabolic world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Nuclear overexpression of NAD(P)H:quinone oxidoreductase 1 in Chinese hamster ovary cells increases the cytotoxicity of mitomycin C under aerobic and hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

The chemical inducibility of mouse cardiac antioxidants and phase 2 enzymes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Oxidative stress and cardiovascular injury: Part II: animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

The effect of NQO1 polymorphism on the inflammatory response in cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes in the Danish population. DIEGG and DSGD. Danish IDDM Epidemiology and Genetics Group and The Danish Study Group of Diabetes in Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9136-9

10.1007/S12012-011-9136-9

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference